These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15238094)

  • 1. In vivo measurement of 5-aminolaevulinic acid-induced protoporphyrin IX photobleaching: a comparison of red and blue light of various intensities.
    Nadeau V; O'Dwyer M; Hamdan K; Tait I; Padgett M
    Photodermatol Photoimmunol Photomed; 2004 Aug; 20(4):170-4. PubMed ID: 15238094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dynamic model for ALA-PDT of skin: simulation of temporal and spatial distributions of ground-state oxygen, photosensitizer and singlet oxygen.
    Liu B; Farrell TJ; Patterson MS
    Phys Med Biol; 2010 Oct; 55(19):5913-32. PubMed ID: 20844331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect.
    Robinson DJ; de Bruijn HS; van der Veen N; Stringer MR; Brown SB; Star WM
    Photochem Photobiol; 1998 Jan; 67(1):140-9. PubMed ID: 9477772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect.
    Robinson DJ; de Bruijn HS; de Wolf WJ; Sterenborg HJ; Star WM
    Photochem Photobiol; 2000 Dec; 72(6):794-802. PubMed ID: 11140268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence photobleaching of ALA and ALA-heptyl ester induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: a comparison of two light sources and different illumination schemes.
    Pudroma X; Juzeniene A; Ma LW; Iani V; Moan J
    J Environ Pathol Toxicol Oncol; 2011; 30(3):235-40. PubMed ID: 22126616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin.
    Wiegell SR; Stender IM; Na R; Wulf HC
    Arch Dermatol; 2003 Sep; 139(9):1173-7. PubMed ID: 12975159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema.
    Mikolajewska P; Iani V; Juzeniene A; Moan J
    Br J Dermatol; 2009 Nov; 161(5):1173-9. PubMed ID: 19785604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome.
    Ericson MB; Sandberg C; Stenquist B; Gudmundson F; Karlsson M; Ros AM; Rosén A; Larkö O; Wennberg AM; Rosdahl I
    Br J Dermatol; 2004 Dec; 151(6):1204-12. PubMed ID: 15606516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irradiance and light dose influence histological localization of photodamage induced by photodynamic therapy with aminolaevulinic acid.
    Bissonnette R; Sharfaei S; Viau G; Liu Y
    Br J Dermatol; 2004 Sep; 151(3):653-5. PubMed ID: 15377353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protoporphyrin IX fluorescence photobleaching and the response of rat Barrett's esophagus following 5-aminolevulinic acid photodynamic therapy.
    Boere IA; Robinson DJ; de Bruijn HS; Kluin J; Tilanus HW; Sterenborg HJ; de Bruin RW
    Photochem Photobiol; 2006; 82(6):1638-44. PubMed ID: 16879035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protoporphyrin IX formation and photobleaching in different layers of normal human skin: methyl- and hexylaminolevulinate and different light sources.
    Togsverd-Bo K; Idorn LW; Philipsen PA; Wulf HC; Hædersdal M
    Exp Dermatol; 2012 Oct; 21(10):745-50. PubMed ID: 22882358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevulinic acid-n-pentylester.
    Gerscher S; Connelly JP; Beijersbergen Van Henegouwen GM; MacRobert AJ; Watt P; Rhodes LE
    Br J Dermatol; 2001 May; 144(5):983-90. PubMed ID: 11359385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring PDT by means of superficial reflectance spectroscopy.
    Amelink A; van der Ploeg van den Heuvel A; de Wolf WJ; Robinson DJ; Sterenborg HJ
    J Photochem Photobiol B; 2005 Jun; 79(3):243-51. PubMed ID: 15896651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy.
    de Bruijn HS; Sluiter W; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
    Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):238-46. PubMed ID: 16948825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protoporphyrin IX fluorescence photobleaching during ALA-mediated photodynamic therapy of UVB-induced tumors in hairless mouse skin.
    Robinson DJ; de Bruijn HS; van der Veen N; Stringer MR; Brown SB; Star WM
    Photochem Photobiol; 1999 Jan; 69(1):61-70. PubMed ID: 10063801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5-aminolaevulinic acid: implications for photodynamic treatment.
    Ross EV; Romero R; Kollias N; Crum C; Anderson RR
    Br J Dermatol; 1997 Nov; 137(5):736-42. PubMed ID: 9415233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring ALA-induced PpIX photodynamic therapy in the rat esophagus using fluorescence and reflectance spectroscopy.
    Kruijt B; de Bruijn HS; van der Ploeg-van den Heuvel A; de Bruin RW; Sterenborg HJ; Amelink A; Robinson DJ
    Photochem Photobiol; 2008; 84(6):1515-27. PubMed ID: 18557821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protoporphyrin IX fluorescence and photobleaching during interstitial photodynamic therapy of malignant gliomas for early treatment prognosis.
    Johansson A; Faber F; Kniebühler G; Stepp H; Sroka R; Egensperger R; Beyer W; Kreth FW
    Lasers Surg Med; 2013 Apr; 45(4):225-34. PubMed ID: 23533060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model.
    Iinuma S; Schomacker KT; Wagnieres G; Rajadhyaksha M; Bamberg M; Momma T; Hasan T
    Cancer Res; 1999 Dec; 59(24):6164-70. PubMed ID: 10626808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study.
    Lange N; Jichlinski P; Zellweger M; Forrer M; Marti A; Guillou L; Kucera P; Wagnières G; van den Bergh H
    Br J Cancer; 1999 Apr; 80(1-2):185-93. PubMed ID: 10389995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.